Inhibrx, Inc. (INBX) Balance Sheet

NASDAQ: INBXAssets, liabilities, debt and equity over 10 years.

INBX balance sheet, 2025

December 31, 2025 · U.S. dollars

$146.5M assets = $138.5M liabilities + $8.0M equity

What it owns$146.5MCash & ST investments: $124.2M (84.8%)Cash & ST investments$124.2M · 85%Receivables: $177,000 (0.1%)Other current: $8.4M (5.8%)Other current $8.4MPP&E: $9.3M (6.3%)PP&E $9.3MOther non-current: $4.4M (3.0%)=How it is financed$146.5MCurrent liabilities: $33.8M (23.1%)Current liabilities$33.8M · 23%Long-term debt: $100.6M (68.7%)Long-term debt$100.6M · 69%Other LT liabilities: $4.1M (2.8%)Shareholders’ equity: $8.0M (5.5%)

Both columns are drawn to the same scale: what INBX owns equals what it owes plus shareholders’ equity. Hover a block for its value.

INBX financial health

Current ratio3.93
Comfortable · current assets cover current liabilities 3.93×
Debt / equity13.39
High leverage · $13.39 of debt for each $1 of equity
Equity / assets5.5%
Thin equity · of assets funded by shareholders
Cash / debt116.1%
Cash covers debt · cash & short-term investments vs total debt
Goodwill & intangibles0.0%
Mostly tangible · of total assets

Descriptive bands, not a rating. Fiscal 2025.

INBX balance sheet trends, 2016–2025

Inhibrx, Inc. balance sheet trends
MetricTrendThenLatestChange
Total assets$21.3M2016$146.5M2025+23.9%/yr
Total liabilities$20.0M2016$138.5M2025+24.0%/yr
Shareholders’ equity−$9.2M2016$8.0M2025—
Cash & short-term investments$20.0M2016$124.2M2025+22.5%/yr
Total debt$18.9M2016$107.0M2025+21.2%/yr
Net cash (debt)$1.1M2016$17.2M2025+$16.1M
Working capital$15.1M2016$99.0M2025+$83.9M
Book value per share−$0.252016$0.522025—
Current ratio3.8720163.932025+0.06
Debt / equity0.50202013.392025+12.89
Shares outstanding36.6M201615.5M2025−9.1%/yr

Change is the average annual growth (CAGR) or the difference between the first and latest year.

INBX assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

INBX liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

INBX debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

INBX balance sheet

Inhibrx, Inc. annual balance sheet
2025202420232022202120202019201820172016
Assets
Cash & short-term investments$124.2M$152.6M$277.9M$273.9M$131.3M$128.7M$11.5M$2.1M$13.5M$20.0M
Cash & equivalents$124.2M$152.6M$277.9M$273.9M$131.3M$128.7M$11.5M$2.1M$13.5M$20.0M
Receivables$177,000$420,000$778,000$257,000$878,000$615,000$438,000$690,000$696,000$0
Inventory$0$0$0−$257,000−$878,000−$129.3M$3.2M$2.3M$999,000$0
Other current assets$8.4M$7.4M$16.7M$6.6M$7.8M$132.2M$376,000$553,000$276,000$383,000
Total current assets$132.8M$160.4M$295.4M$280.5M$139.1M$132.2M$15.6M$5.7M$15.4M$20.4M
Property, plant & equipment (net)$9.3M$13.5M$9.4M$7.2M$9.5M$11.3M$10.7M$2.6M$1.8M$864,000
Goodwill & intangible assets$0$0$0$0$0$0$0$0$0$0
Long-term investments$0$0$0$0$0$0$0$0$0$0
Other non-current assets$4.4M$6.8M$3.2M$3.2M$1.8M$245,000$245,000$1.7M$0$0
Total assets$146.5M$180.8M$307.9M$290.9M$150.4M$143.7M$26.5M$10.0M$17.2M$21.3M
Liabilities
Accounts payable$5.9M$9.2M$11.0M$8.3M$9.1M$13.5M$3.1M$6.5M$775,000$167,000
Short-term debt$2.3M$1.6M$2.1M$1.9M$1.7M$1.5M$4.7M$5.9M$5.2M$4.3M
Deferred revenue———$166,000$2.0M$3.1M$7.9M$1.6M$2.6M—
Total current liabilities$33.8M$40.7M$56.3M$27.6M$22.5M$31.4M$20.6M$16.2M$8.9M$5.3M
Long-term debt$100.6M$0$207.0M$0$0$0$0$0$0$0
Lease obligations$6.5M$8.0M$3.2M$5.0M——————
Other long-term liabilities$4.1M$6.5M$1.1M$205.2M$75.6M$36.9M$99.5M$51.4M$30.7M$14.8M
Total liabilities$138.5M$47.2M$264.4M$232.8M$98.1M$68.3M$120.1M$67.6M$39.7M$20.0M
Shareholders' equity
Common stock & paid-in capital$1,000$1,000$5,000$4,000$4,000$4,000$2,000$3,000——
Retained earnings (deficit)−$246.2M−$106.1M−$613.7M−$372.4M−$227.1M−$145.4M−$69.3M−$17.9M−$28.8M−$9.2M
Accumulated other comprehensive income——$0—−$150.4M−$143.7M−$59.5M−$1.7M−$1.0M—
Total shareholders' equity$8.0M$133.6M$43.5M$58.1M$52.4M$75.5M−$93.6M−$57.6M−$28.8M−$9.2M
Key figures
Total debt$107.0M$8.0M$210.1M$207.1M$72.1M$37.5M$41.7M$9.5M$14.7M$18.9M
Net cash (debt)$17.2M$144.5M$67.8M$66.8M$59.2M$91.2M−$30.2M−$7.4M−$1.2M$1.1M
Working capital$99.0M$119.7M$239.0M$252.9M$116.7M$100.8M−$5.0M−$10.5M$6.5M$15.1M
Tangible book value$8.0M$133.6M$43.5M$58.1M$52.4M$75.5M−$93.6M−$57.6M−$28.8M−$9.2M
Book value per share$0.52$9.23$0.92$1.45$1.38$2.99−$2.56−$2.13−$1.00−$0.25
Shares outstanding15.5M14.5M47.1M40.1M38.0M25.3M36.6M27.1M28.8M36.6M
Current ratio3.933.945.2510.176.204.210.760.351.733.87
Quick ratio3.683.764.959.945.894.120.580.171.593.79
Debt / equity13.390.064.833.571.380.50————
Equity / assets5.5%73.9%14.1%20.0%34.8%52.5%−353.2%−577.4%−166.8%−43.5%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 19, 2026); data from EODHD.

INBX financial position

At the end of fiscal 2025 (December 31, 2025), Inhibrx had total assets of $146.5 million (down 19.0% from a year earlier), total liabilities of $138.5 million and shareholders' equity of $8.0 million. It held $124.2 million in cash and short-term investments against $107.0 million of debt, a net cash position of $17.2 million. Its current ratio was 3.93. In the latest quarter (ended June 30, 2026) total assets were $154.2 million and equity -$53.0 million.

Related: INBX income statement, INBX cash flow statement, INBX key metrics. See the INBX stock overview for the latest quote and news.

INBX balance sheet FAQ

What are Inhibrx's total assets?

Inhibrx reported total assets of $146.5 million at the end of fiscal 2025 (December 31, 2025), compared with $180.8 million a year earlier.

How much debt does Inhibrx have?

Inhibrx had $107.0 million of total debt at the end of fiscal 2025, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 13.39.

How much cash does Inhibrx have?

Inhibrx held $124.2 million in cash and short-term investments at the end of fiscal 2025; with $107.0 million of debt that is net cash of $17.2 million.

What is Inhibrx's book value?

Inhibrx's shareholders' equity (book value) was $8.0 million at the end of fiscal 2025, or $0.52 per share.

What is Inhibrx's current ratio?

Inhibrx had current assets of $132.8 million and current liabilities of $33.8 million, a current ratio of 3.93 (it can cover its short-term obligations).

Biotechnology: balance sheet